ASIC4 | Acid-sensing (proton-gated) ion channel family member 4 | Predicted membrane proteins
| | | | | Group enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
BRINP2 | Bone morphogenetic protein/retinoic acid inducible neural-specific 2 | Predicted secreted proteins
| | | | | Group enriched |
CALY | Calcyon neuron-specific vesicular protein | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
CPLX2 | Complexin 2 | | | | | | Group enriched |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Group enriched |
FAM163B | Family with sequence similarity 163, member B | Predicted membrane proteins
| | | | | Group enriched |
FNDC9 | Fibronectin type III domain containing 9 | Predicted membrane proteins
| | | | | Group enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
GPR98 | G protein-coupled receptor 98 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
GRIK1 | Glutamate receptor, ionotropic, kainate 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | | | Group enriched |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
LUZP2 | Leucine zipper protein 2 | Predicted secreted proteins
| | | | | Group enriched |
MYT1 | Myelin transcription factor 1 | Plasma proteins Transcription factors
| | | | | Group enriched |
NRCAM | Neuronal cell adhesion molecule | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NSG2 | Neuron-specific protein family member 2 | Predicted membrane proteins
| | | | | Group enriched |
NXPH1 | Neurexophilin 1 | Predicted secreted proteins
| | | | | Group enriched |
SCG2 | Secretogranin II | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SEZ6L | Seizure related 6 homolog (mouse)-like | Predicted membrane proteins
| | | | | Group enriched |
SHANK1 | SH3 and multiple ankyrin repeat domains 1 | Plasma proteins
| | | | | Group enriched |
SLC24A2 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
STMN2 | Stathmin-like 2 | | | | | | Group enriched |
SYNGR3 | Synaptogyrin 3 | Predicted membrane proteins
| | | | | Group enriched |
SYT4 | Synaptotagmin IV | | | | | | Group enriched |
TMEM179 | Transmembrane protein 179 | Predicted membrane proteins
| | | | | Group enriched |
UCHL1 | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
UNC5A | Unc-5 homolog A (C. elegans) | Predicted membrane proteins
| | | | | Group enriched |